Skip to main content

Glenview Trust Co

Bank

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1691827 Louisville, KY

Position in REGN

as of Jun 30, 2026 · filed Aug 18, 2026
Position Value
$2,746,070
-$319,765 QoQ
Shares Held
4,404
+11.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#473
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Glenview Trust Co holds $7,217,996 across 4 Biotechnology names. REGN ranks #2 (38.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 REGN
Regeneron Pharmaceuticals, Inc.
This page
4,404 $2,746,070

All Filings in REGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,746,070 4,404
2026-03-31 $3,065,835 3,968
2025-12-31 $3,065,095 3,971
2025-09-30 $2,231,087 3,968
2025-06-30 $2,088,450 3,978
2025-03-31 $2,229,318 3,515
2024-12-31 $2,187,565 3,071
2024-09-30 $3,202,077 3,046
2024-06-30 $3,201,437 3,046
2024-03-31 $2,934,632 3,049
2023-12-31 $2,677,906 3,049
2023-09-30 $2,540,477 3,087
2023-06-30 $2,197,295 3,058
2023-03-31 $2,538,138 3,089
2022-12-31 $2,228,682 3,089
2022-09-30 $1,986,701 2,884
2022-06-30 $1,507,972 2,551
2022-03-31 $1,765,605 2,528
2021-12-31 $1,597,114 2,529
2021-09-30 $1,594,044 2,634
2021-06-30 $1,457,230 2,609
2021-03-31 $1,163,451 2,459
2020-12-31 $1,199,562 2,483
2020-09-30 $1,396,651 2,495
2020-06-30 $2,039,335 3,270
2020-03-31 $1,591,825 3,260